OneFund LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$345K Sell
5,596
-262
-4% -$15.3K 0.22% 82
2025
Q4
$316K Buy
5,858
+327
+6% +$15.7K 0.19% 98
2025
Q3
$249K Buy
5,531
+201
+4% +$9.39K 0.16% 117
2025
Q2
$247K Sell
5,330
-39
-0.7% -$1.91K 0.18% 112
2025
Q1
$327K Buy
5,369
+2
+0% +$117 0.33% 79
2024
Q4
$304K Buy
5,367
+43
+0.8% +$2.4K 0.29% 83
2024
Q3
$275K Buy
5,324
+7
+0.1% +$328 0.28% 95
2024
Q2
$221K Buy
5,317
+80
+2% +$3.58K 0.24% 109
2024
Q1
$278K Sell
5,237
-145
-3% -$7.39K 0.33% 84
2023
Q4
$276K Buy
+5,382
New +$283K 0.36% 81

Other funds holding BMY

OneFund LLC's BMY Position: Q1 2026 in Review

OneFund LLC reduced its Bristol-Myers Squibb (BMY) stake by 4.5% in Q1 2026, selling an estimated $15.3K and leaving 5,596 shares worth $345K. The position accounts for 0.22% of the portfolio, ranked #82.

OneFund LLC first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • OneFund LLC held 5,596 shares of Bristol-Myers Squibb worth $345K as of Q1 2026.
  • OneFund LLC sold 262 Bristol-Myers Squibb shares in Q1 2026, an estimated $15.3K.
  • Bristol-Myers Squibb made up 0.22% of OneFund LLC's portfolio in Q1 2026, its #82 holding.
  • OneFund LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.